Gwenn Hansen - Net Worth and Insider Trading

Gwenn Hansen Net Worth

The estimated net worth of Gwenn Hansen is at least $1 Million dollars as of 2024-11-05. Gwenn Hansen is the Chief Scientific Officer of Nurix Therapeutics Inc and owns about 50,670 shares of Nurix Therapeutics Inc (NRIX) stock worth over $1 Million. Details can be seen in Gwenn Hansen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gwenn Hansen has not made any transactions after 2024-10-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gwenn Hansen

To

Gwenn Hansen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gwenn Hansen owns 1 companies in total, including Nurix Therapeutics Inc (NRIX) .

Click here to see the complete history of Gwenn Hansen’s form 4 insider trades.

Insider Ownership Summary of Gwenn Hansen

Ticker Comapny Transaction Date Type of Owner
NRIX Nurix Therapeutics Inc 2024-07-30 Chief Scientific Officer

Gwenn Hansen Latest Holdings Summary

Gwenn Hansen currently owns a total of 1 stock. Gwenn Hansen owns 50,670 shares of Nurix Therapeutics Inc (NRIX) as of October 30, 2024, with a value of $1 Million.

Latest Holdings of Gwenn Hansen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NRIX Nurix Therapeutics Inc 2024-10-30 50,670 25.43 1,288,538

Holding Weightings of Gwenn Hansen


Gwenn Hansen Form 4 Trading Tracker

According to the SEC Form 4 filings, Gwenn Hansen has made a total of 22 transactions in Nurix Therapeutics Inc (NRIX) over the past 5 years, including 0 buys and 22 sells. The most-recent trade in Nurix Therapeutics Inc is the sale of 3,437 shares on October 30, 2024, which brought Gwenn Hansen around $83,554.

Insider Trading History of Gwenn Hansen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gwenn Hansen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gwenn Hansen Ownership Network

Ownership Network List of Gwenn Hansen

No Data

Ownership Network Relation of Gwenn Hansen

Insider Network Chart

Gwenn Hansen Owned Company Details

What does Nurix Therapeutics Inc do?

Who are the key executives at Nurix Therapeutics Inc?

Gwenn Hansen is the Chief Scientific Officer of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Financial Officer Houte Hans Van , and EVP and COO Stefani Wolff .

Nurix Therapeutics Inc (NRIX) Insider Trades Summary

Over the past 18 months, Gwenn Hansen made 6 insider transaction in Nurix Therapeutics Inc (NRIX) with a net sale of 14,703. Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 67,327 shares made by Christine Ring , a net sale of 82,022 shares made by Houte Hans Van ,

In summary, during the past 3 months, insiders sold 70,553 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 70,553 shares. During the past 18 months, 164,052 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 164,052 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nurix Therapeutics Inc Insider Transactions

No Available Data

Gwenn Hansen Mailing Address

Above is the net worth, insider trading, and ownership report for Gwenn Hansen. You might contact Gwenn Hansen via mailing address: C/o Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco Ca 94158.